Search Results for keywords:"registration application"

Found 10 results
Skip to main content

Search Results: keywords:"registration application"

  • Type:Notice
    Citation:86 FR 3197
    Reading Time:about a minute or two

    IsoSciences, LLC has applied to the Drug Enforcement Administration to become a bulk manufacturer of certain controlled substances. They plan to create synthetic versions of Marihuana and Tetrahydrocannabinols for use in analytical testing, and no other activities for these drugs are permitted with this registration. The public has until March 15, 2021, to submit written comments or objections, or to request a hearing regarding this application.

    Simple Explanation

    IsoSciences, LLC wants to make pretend versions of some special plants and substances to help scientists test them. People have until March 15, 2021, to say if they agree or disagree with this plan.

  • Type:Notice
    Citation:90 FR 16554
    Reading Time:about a minute or two

    Patheon API Services Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances. This registration is intended to support the clinical trials of their customers. Interested parties are invited to submit comments or objections electronically through the Federal eRulemaking Portal by June 17, 2025. They may also request a hearing on the application by the same date.

    Simple Explanation

    Patheon API Services Inc. wants to make some special medicines and needs permission from a government group called the DEA. People can say what they think about this or ask for a meeting about it before June 17, 2025.

  • Type:Notice
    Citation:90 FR 16555
    Reading Time:about a minute or two

    Stepan Company has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of certain controlled substances. This request was made on January 31, 2025, and is currently open for public comment until June 17, 2025. Individuals who are already registered manufacturers of these substances or are applicants for such a registration can submit their comments or objections electronically through the Federal eRulemaking Portal. Interested parties may also request a hearing on this application before the deadline if desired.

    Simple Explanation

    Stepan Company wants permission to make certain special substances, and people can say if they think it's a good or bad idea until June 17, 2025, but we don't know which substances or how this decision might affect others.

  • Type:Notice
    Citation:86 FR 11333
    Reading Time:about a minute or two

    Globyz Pharma, LLC has applied to the Drug Enforcement Administration (DEA) for registration as an importer of controlled substances for analytical testing. The application does not authorize any other activities, such as importing FDA-approved finished dosage forms for sale. Interested parties, including registered manufacturers, can submit comments or objections, or request a hearing regarding this application by March 26, 2021. The DEA's decision will be based on alignment with legal requirements under 21 U.S.C. 952(a)(2).

    Simple Explanation

    Globyz Pharma, a company, wants permission to bring in special medicines for testing, but they can't sell the medicines. People can share their thoughts or ask for a meeting to talk about it before the end of March 2021.

  • Type:Notice
    Citation:90 FR 9555
    Reading Time:about a minute or two

    Maridose LLC has put in an application to register as a bulk manufacturer of certain controlled substances. This application is directed to the Drug Enforcement Administration (DEA) and aims to supply these substances to DEA-registered researchers for their approved studies. Interested parties, such as other registered manufacturers, have until April 14, 2025, to submit comments or objections electronically through the Federal eRulemaking Portal. They can also request a hearing on the application by this deadline.

    Simple Explanation

    Maridose LLC wants to make certain special medicines for research, and they have asked for permission to do this. People who are interested can say what they think about this plan until April 14, 2025.

  • Type:Notice
    Citation:90 FR 7173
    Reading Time:about a minute or two

    The Drug Enforcement Administration (DEA) has announced that Siegfried USA, LLC, located in Pennsville, New Jersey, has applied to be registered as a bulk manufacturer of certain controlled substances. Interested parties, including registered manufacturers of these substances, can submit comments or objections electronically by March 24, 2025. They can also request a hearing on the application by the same date. This registration will allow Siegfried USA to produce these substances in bulk for sale.

    Simple Explanation

    Siegfried USA, a company in New Jersey, wants permission to make special medicine ingredients in large amounts, and people can tell the government what they think about this by March 24, 2025.

  • Type:Notice
    Citation:89 FR 102214
    Reading Time:about 4 minutes

    On September 19, 2024, MX2 LLC applied to the Securities and Exchange Commission (SEC) for registration as a national securities exchange under the Securities Exchange Act of 1934. The company later submitted an amendment to its application on November 29, 2024. MX2 plans to operate an automated electronic trading platform without a physical trading floor, allowing broker-dealer members to trade NMS stocks. The SEC is seeking public comments on MX2's application to determine if it meets the necessary requirements and will decide whether to grant the registration based on these assessments.

    Simple Explanation

    MX2 LLC wants permission to start a new stock trading place online, where people can buy and sell shares using computers instead of going to a real building. The government is asking people to say what they think about this idea to help decide if it's okay.

  • Type:Notice
    Citation:90 FR 9733
    Reading Time:about a minute or two

    Patheon API Inc. has applied to the Drug Enforcement Administration to register as a bulk manufacturer of several controlled substances. The registration would allow the company to import these substances as reference standards for research and development in its API Manufacturing operations. Interested parties, including current registered bulk manufacturers, can submit comments or objections electronically by April 21, 2025, and may also request a hearing on the application by the same date. Comments submitted will be tracked, and successful submissions will receive a Comment Tracking Number.

    Simple Explanation

    Patheon API Inc. wants permission to make special medicines, and people can share their thoughts about it until April 21, 2025. They need to let an official group called the Drug Enforcement Administration know what they think and follow some rules to do so.

  • Type:Notice
    Citation:86 FR 8977
    Reading Time:about 34 minutes

    The Securities and Exchange Commission (SEC) has received an application from DTCC Data Repository (U.S.) LLC (DDR) to be registered as a Security-Based Swap Data Repository (SDR) and a Securities Information Processor (SIP). DDR intends to handle data for transactions involving equity, credit, and interest rate derivatives. The SEC is seeking public comments on this application to help decide whether to approve it. The application outlines how DDR plans to manage its operations, ensure security, and handle compliance with legal requirements.

    Simple Explanation

    The SEC is thinking about letting a company called DDR keep track of special trading data to help people understand big financial trades. They want to know what people think about this idea before saying yes or no.

  • Type:Notice
    Citation:90 FR 11078
    Reading Time:about 3 minutes

    Dream Exchange Holdings, Inc. has applied to the Securities and Exchange Commission (SEC) for registration as a national securities exchange under the Securities Exchange Act of 1934. The SEC is asking for public comments on Dream's proposal, which outlines how Dream plans to meet the legal requirements. Dream Exchange would operate an automated platform for trading stocks and would not have a physical trading floor. The public can view Dream's detailed application online and submit comments until April 17, 2025.

    Simple Explanation

    Dream Exchange wants to start a new place to trade stocks online, and they're asking for permission from a big government group. People can share their thoughts about this until April 17, 2025.